Phenotypic Screening

As an expert in drug research, Creative Biolabs can provide customers with drug research services covering various targets and disease fields, from active compound discovery, target verification, lead compound optimization to preclinical drug candidate selection.

Finding effective and safe drugs is the main purpose of drug research. To filter multiple compounds with different chemical structures with higher clinical medicinal potential and optimizing lead compounds will greatly accelerate the process of drug exploration. Phenotypic screening has gradually emerged in drug discovery.

Introduction of Phenotypic Screening

Phenotypic drug screening is a method based on changes in the phenotype of organisms. Biological phenotypes are the characteristics of specific genes under the influence of the environment. Traditional phenotypic screening is the standard method for new drug invention. It mainly filters compounds that can change the phenotype in animal disease models and then studies the targets and mechanisms of the compounds. Later, modern cell-based phenotypic screening technology appeared. This technology is mainly used to screen compounds that can cause desired physiological changes in cells, which helps to discover new proteins and new targets.

Molecular target-based and phenotype-based assays. Fig.1 Molecular target-based and phenotype-based assays. (Henry, 2019)

Features of Phenotypic Screening

The exploration of drugs by phenotype-based compound screening technology is achieved through changes in complex biological systems or signal pathways by compounds, and it is an effective way to probe compounds that act on new targets. The use of this simple strategy not only helps to increase the probability of early drug detection but also improves the success rate of late drug development. Modern phenotypic screening technology will be more meaningful for the investigation of rare disease drugs and novel drug targets. Moreover, this technology is minimally affected by molecular insight. Therefore, this characteristic can be applied to the discovery of new drugs in diseases where the underlying mechanism is not well understood, such as common psychosomatic diseases or neurological diseases. At present, some research statistics show that the number of drugs discovered by modern phenotypic screening methods has exceeded the number discovered based on molecular targets. Therefore, modern phenotypic screening will become a promising drug prospecting approach.

Applications of Phenotypic Screening

Based on the above advantages, phenotypic screening has been used in the exploration of a variety of drugs. For example, digoxin from foxglove, morphine from poppy, and aspirin from salicylic acid. This has led to the use of animal and microbial phenotypic screening to isolate most antibiotics and many other compounds in clinical use today. In addition, compounds obtained through phenotypic screening of natural products have led to the recognition of opioid receptors, transpeptidase, and many other enzymes and transporters. The recent examples of approved drugs discovered through phenotypic screening further demonstrate the potential of this technology in finding highly selective targeted therapies. These examples include drugs that target ubiquitously expressed key cell function regulators.

We have completed dozens of drug research and development cooperation projects with global customers and accumulated rich experience. Creative Biolabs has been equipped to provide our customers with professional and efficient phenotypic screening services. If you need help in drug research, please contact us as soon as possible.

Reference

  1. Henry, J.; Wlodkowic, D. Towards high-throughput chemobehavioural phenomics in neuropsychiatric drug discovery. Marine drugs. 2019, 17(6): 340.
For Research Use Only
Online Inquiry

Let's Get Started

Contact Us

USA

UK

Follow us on

Copyright © 2022 Creative Biolabs. All Rights Reserved.